Document is current
Any future updates will be listed below
-
Authors
Abdelgawad, Ahmed
Nicola, Teodora
Martin, Isaac
Halloran, Brian A.
Tanaka, Kosuke
Adegboye, Comfort Y.
Jain, Pankaj
Ren, Changchun
Lal, Charitharth V.
Ambalavanan, Namasivayam
O’Connell, Amy E.
Jilling, Tamás
Willis, Kent A.
-
Funding
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (K08 HL151907; K08 HL141652; 1U01ES027697; R21ES031559, K08 HL151907; K08 HL141652; 1U01ES027697; R21ES031559, K08 HL151907; K08 HL141652; 1U01ES027697; R21ES031559, K08 HL151907; K08 HL141652; 1U01ES027697; R21ES031559)
National Institute of Diabetes and Digestive and Kidney Diseases (K08 DK120871)
- License Information
-
More Information
Article History
Received: 17 March 2023
Accepted: 21 September 2023
First Online: 16 October 2023
Declarations
:
: No human subjects. Animal experimentation was performed at the University of Alabama at Birmingham under IACUC protocol 22042.
: Not applicable (No human subjects).
: CL is the founder and CEO of Alveolus Bio and Resbiotic, Inc., NA and KW are advisors, and TN is now an employee.
